Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Postural Orthostatic Tachycardia Syndrome 1Mastocytosis 1Leukemia, Myelomonocytic, Chronic 1Bronchopulmonary Disease 1

Interventions

Specimen Handling 125pembrolizumab 123Magnetic Resonance Spectroscopy 108Carboplatin 89Cyclophosphamide 80Biopsy 69Cisplatin 67Paclitaxel 61Bevacizumab 56Gemcitabine 54Nivolumab 49fludarabine 48Dexamethasone 41Rituximab 39Pemetrexed 39Fluorouracil 39Radiotherapy 37Doxorubicin 37atezolizumab 36Docetaxel 36Leucovorin 35Oxaliplatin 32Capecitabine 32venetoclax 31Temozolomide 29Prednisone 29durvalumab 27Standard of Care 27Radiation 27Letrozole 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Mass Screening × 30 days × Clear all
NCT06439901 2026-06-02

OPTI-DEPIST

Institut Curie

Phase NA Recruiting
500 enrolled

Bronchopulmonary Disease

NCT06042543 2026-06-01

EASTER

International Agency for Research on Cancer

Phase NA Recruiting
3,200 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT07143669 2026-05-22

Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations

Blueprint Medicines Corporation

Recruiting
450 enrolled
MyeloidOther hematologic neoplasm

Mastocytosis, Leukemia, Myelomonocytic, Chronic, Postural Orthostatic Tachycardia Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡